A fully human anti-CD4 antibody: Phase II trial in cutaneous T-cell lymphoma - 21/08/11
Doi : 10.1016/j.jaad.2004.10.579
Le texte complet de cet article est disponible en PDF.
Youn H. Kim, MD, Stanford University Medical Center, Department of Dermatology, Stanford, CA, United States; Madeleine Duvic, MD, M. D. Anderson Cancer Center, Unit 434, Dermatology, Houston, TX, United States; Susan J. Knox, MD, PhD, Stanford University Medical Center, Department of Radiation Oncology, Stanford, CA, United States; Ole Baadsgaard, MD, Genmab A/S, Copenhagen, Denmark
Le texte complet de cet article est disponible en PDF.| P2124 Susan J. Knox has received a salary support for the task as Coordinating Investigator in the trial sponsored by Genmab A/S. Ole Baadsgaard is an employee of Genmab A/S (trial sponsor) and has stock options and financial interest in Genmab A/S. Youn H. Kim has no financial interest in Genmab A/S. Madeleine Duvic has no financial interest in Genmab A/S. Poster development including printing sponsored by Genmab A/S |
© 2005
American Academy of Dermatology, Inc.. Publié par Elsevier Masson SAS. Tous droits réservés.
Vol 52 - N° 3S
P. P143 - mars 2005 Retour au numéro
Article précédent
- Can patients without melanoma understand the impact of melanoma?
- Transformed mycosis fungoides in a married couple: Temporal coincidence or environmental consequence?
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?